Most Recent
Drug giant Pfizer has blasted Samsung Bioepis' “fishing expedition” in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity.
Fortescue has brought legal action against start-up Element Zero and three former employees, alleging “industrial scale misuse” of the Western Australian mining company's confidential information.
The corporate regulator is on a winning streak in its greenwashing cases, with a judge rejecting Active Super's attempt to qualify its “unequivocal” statements about limiting its investment in companies connected to gambling and coal mining.
The co-owners of Pacific Werribee shopping centre in Victoria have largely won their bid for insurance documents as they weigh a second case against collapsed construction company Probuild, allegedly worth up to $335 million.
The online safety watchdog has dropped her Federal Court action seeking to force X to put a worldwide block on graphic footage of the April stabbing of a religious leader at Wakeley, following a judge's decision not to maintain an injunction against the social media platform.
A judge has allowed a coal mine truck driver to bring claims as much as five years out of time against Mt Arthur Coal and Chandler Macleod over alleged bullying by a colleague, finding the delay in bringing the case was justified by a period of disability which left the worker “severely impaired in her capacity to pursue any litigation”.
Industrial technology company Delta Building Automation has been hit with a $1.5 million penalty after it was found liable for attempting to rig a bid for construction work on the National Gallery of Australia, a penalty five times the sum it asked the court to impose.
MinterEllison’s Perth office has welcomed a new energy and resources expert from Dentons, fleshing out the firm's Western Australian capabilities.
The Australian Energy Regulator has secured a $2.75 million penalty in a case against oil and gas company Santos alleging record-keeping failures in breach of the National Gas Rules.
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company's failure to comply with an earlier ruling.